Arkolith/Insider Trading/XTNT/Form 4

Vizirgianakis Stavros G.

DirectorXtant Medical Holdings, Inc. (XTNT) · full profile →Form 4 · filed Oct 11, 2022
Net Buying
Open-Market Buys
$1.1M
Open-Market Sells
$0
Net Open-Market Flow
$1.1M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2022Buy(P)2.3M$0.48$1.1M5.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2022Buy(P)566K—$0566K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-22-000113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML